Peter Sjöstrand

Peter Sjöstrand is currently the Chairman of Life Science Imaging at Karolinska Institutet, Chairman of Stiftelsen Oscar Hirsch Minne, Chairman of Byggnads AB S:t Erik, Chairman of Mallax Pharmaceuticals AB, Director at Fora AB, Director at Ringens Varv AB, Director at Dr. Sjöstrand AB, Director at Disruptive Materials AB, Director at SAMF Sweden AB, Director at Mlerifakta AB, and a Member of the Strategic Council at the Royal Institute of Technology.
In the past, Dr. Sjöstrand served as the Vice Chairman of Advanced Oncotherapy Plc from 2018 to 2020, Chairman of Gambro AB from 2006 to 2010, Chairman of Meda AB from 2000 to 2009, Chairman of Incentive AB, Chairman of Aleris Holding AB, Chairman of Gambro Lundia AB, Chairman of Rossholmen AB, Chairman of Prebona AB, Director at Astra AB in 1993, Director at Tularik, Inc., Independent Director at Active Biotech AB from 2000 to 2020, Director at Medivir AB, Director at Linde Sverige AB, Director at Trygg-Hansa Liv, Director at ZKB Pharma Vision AG from 1993 to 2000, Chief Financial Officer, Director & EVP at Astra Group, Inc. (Georgia) from 1976 to 1993, Independent Director at Karolinska Development AB from 2008 to 2012, Director at Mediject AB, Director at Calmark Sweden AB, Director at Slutsteget Nr 26 AB, Director at Acturum Life Science AB, Director at Microdrug AG, and Director at Spatial Transcriptomics AB. Dr. Sjöstrand holds a doctorate degree from Karolinska Institutet and an undergraduate degree from Stockholm School of Economics.